Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Don't get hacked! Research shows how much we ignore online warnings

  • Tapeworm found living inside a patient's brain: Worm removed and sequenced

  • E-cigarettes significantly reduce tobacco cravings, study suggests

  • Coping strategies therapy significantly improves dementia carers' mental health, quality of life

  • Fathers' engagement with baby depends on mother

  • Unstable child care can affect children by age four

  • Self-regulation intervention boosts school readiness of at-risk children, study shows

  • Rejecting unsuitable suitors is easier said than done

  • Reported opioid abuse in pregnant women more than doubles in 14 years

  • Computerized cognitive training has modest benefits for cognitively healthy older adults

  •